The success of Viagra initially sparked a boom for major pharmaceutical companies, but recent shifts present a complicated scenario for those considering a stake. Off-patent versions are reducing profits, and continued https://umairfepz807324.total-blog.com/the-blue-pill-and-big-pharma-a-volatile-play-66696184